CDC recommends rationing of RSV shot due to shortages
The Centers for Disease Control and Prevention has recommended rationing an important monoclonal antibody product to protect young infants from RSV due to strained supply of the new product, Sanofi’s Beyfortus.
In a health alert issued Monday, the CDC said clinicians should prioritize available doses for babies at highest risk from respiratory syncytial virus, reserving 100-mg doses for infants under the age of 6 months and those with underlying health conditions that put them at higher risk of experiencing severe illness if they contract RSV.
Read Original Article: CDC recommends rationing of RSV shot due to shortages »
